Thorough Future secures Series A++ funding for global expansion of AI-powered pathology

Thorough Future, a global leader in the field of intelligent pathology, recently announced the successful completion of its A++ round of financing. This round was led by Bridgeone Capital, with I&R Capital acting as the exclusive financial advisor for the transaction.

Thorough Future has significantly released the Thorough Brain, a foundational model for pathology. Leveraging massive pathological data and an advanced Transformer architecture, this model has deeply learned from digital pathology data encompassing dozens of major human organs, establishing a comprehensive foundational understanding of pathological tissue morphology across these organs. It creates an exceptionally solid technical foundation for various applications within the field of intelligent pathology. This innovation not only substantially enhances the accuracy and efficiency of pathological diagnosis but also provides novel solutions to the challenges faced in traditional pathological diagnostics.

In terms of clinical application, the Thorough Brain pathology foundation model has demonstrated robust capabilities and extensive applicability, having been successfully deployed nationwide across China. Notably, within the digital intelligence infrastructure development of Hubei Province, the model has played a pivotal AI-enabled role. It has provided substantial support for pathological diagnosis and medical services in local healthcare institutions, significantly enhancing the quality and efficiency of regional pathological diagnostics and enabling more patients to benefit from advanced intelligent pathology technology.

Beyond the exceptional performance of its pathology foundation model, Thorough Future has also achieved substantial results in product development and innovation. In May 2025, the company launched its latest flagship product for the intelligent pathology diagnosis platform—Thorough Insights v5.0. This product represents a major breakthrough in algorithm optimization, resulting in more precise and reliable diagnostic outcomes. Furthermore, the addition of new features and intelligent integration with Pathology Information Systems provide pathologists with more practical diagnostic tools and diverse options. The redesigned diagnostic interface, which fully considers pathologists' workflow habits, significantly enhances usability and work efficiency, delivering a superior user experience.

The proceeds from this A++ financing round will be primarily used to further advance the clinical application and promotion of the Thorough Brain pathology foundation model and to accelerate the global deployment of the digital-intelligent pathology department solution. Thorough Future plans to strengthen in-depth collaborations with top-tier medical and research institutions, both domestically and internationally, to actively pursue more forward-looking and innovative clinical trials and research projects. This effort aims to continuously optimize and enhance its products and services to meet the needs of patients and healthcare institutions across different global regions. Concurrently, the company will increase investment in talent development and technological R&D to attract more industry elites, thereby boosting its core competitiveness and providing more precise, efficient, and personalized medical services to patients worldwide.